Android app Apple app link

Nektar Therapeutics (NKTR) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$62.5
Day's range
$69.49

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/22/2026 Canaccord Genuity Edward Nash $153.00 $68.67   122.8%
05/11/2026 Wedbush Martin Fan $80.00 $81.89   -2.31%
05/08/2026 Piper Sandler Yasmeen Rahimi $192.00 $83.37   130.3%
03/13/2026 Oppenheimer Jay Olson $140.00 $73.27   91.07%
01/26/2026 Piper Sandler Yasmeen Rahimi $105.00 $36.35   188.86%
12/16/2025 Oppenheimer Jay Olson $115.00 $50.43   128.04%
11/24/2025 Jefferies Roger Song $121.00 $54.28   122.92%
09/18/2025 Jefferies Roger Song $99.00 $58.74   68.54%
04/17/2022 Mizuho Securities Mara Goldstein $6.00 $4.74   26.58%
02/28/2022 J.P. Morgan Jessica Fye $17.00 $10.98   54.83%
11/07/2021 Ladenburg Thalmann & Co. Aydin Huseynov $20.00 $14.65   36.52%
05/17/2021 Goldman Sachs Chris Shibutani $24.00 $18.13   32.38%

Nektar Therapeutics FAQ's

Nektar Therapeutics has been rated by research analysts at Canaccord Genuity, Wedbush, Piper Sandler, H.C. Wainwright, Oppenheimer, BTIG in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.